Marking of bottles and other containers

(1) Subject to subregulation (2), no person shall supply a controlled drug otherwise than in a bottle, package or other container which is plainly marked– (a) in the case of a controlled drug other than a preparation, with the amount of the drug contained therein; (b) in the case of a controlled drug which is a preparation34 Misuse of Drugs (i) made up into tablets, capsules or other dosage units, with the amount of each component (being a controlled drug) of the preparation in each dosage unit and the number of dosage units in the bottle, package or other container; (ii) not made up as aforesaid, with the total amount of the preparation in the bottle, package or other container and the percentage of each of its components which is a controlled drug. (2) Nothing in this regulation shall have effect in relation toSchedules IV (a) the drugs specified in Schedule IV and V or (b) any drug specified in Schedule III contained in or comprising a preparation which– (i) is required for use as a buffering agent in chemical analysis; (ii) has present in it both a substance specified in paragraph 1 or 2 of that Schedule and a salt of that substance; and (iii) is premixed in a kit; (c) the supply of a controlled drug by or on the prescription of a practitioner; (d) the supply of a controlled drug for administration in a clinical trial or a medicinal test on animals. Misuse of Drugs 35 (3) In this regulation, the expression “clinical trial” means an investigation or series of investigations consisting of the administration of one or more medicinal products by or under the direction of a doctor or dentist or several doctors or dentists to one or more patients for the purpose of ascertaining whether and to what extent the product has or products have effects beneficial or harmful to the patients in question; and “medicinal test on animals” means an investigation or series of investigations consisting of the administration of one or more medicinal products by or under the direction of authorised veterinary practitioners to one or more animals for the purpose of ascertaining whether and to what extent the product has or products have effects which are beneficial or disadvantageous to the animals or are relevant to a medicinal purpose.